BioSpace News Archive

Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the appointment of Dr. Monica P. Reed, a former AdventHealth executive, to its board of directors effective April 22, 2021.

AccessDX Laboratory, an international provider of advanced laboratory diagnostics solutions, announced its strategic partnership with JASE Health, a leading technology and professional services provider of end-to-end integration solutions with major electronic medical record systems.

Mediso Medical Imaging Systems today announced that it has completed the technology transfer of the new Cameleon4™ MRI spectrometer developed by RS2D (Strasbourg, France).

Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, today announced the appointment of Vatnak Vat-Ho to the role of Chief Business Officer.

Synaptogenix, Inc. (OTC: SNPX) (“Synaptogenix” or the “Company”), an emerging biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced that Dr. Daniel Alkon, the Company’s President and Chief Scientific Officer, will present a “Spotlight Showcase” of Synaptogenix under the title “Regenerative Therapeutics”

XPRIZE, AirMiners and Creative Destruction Lab (CDL) today announced a partnership to support early-stage carbon removal startups interested in the $100M XPRIZE Carbon Removal competition

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, and Verily, a subsidiary of Alphabet focused on life sciences and healthcare, today announced that the first patient has been enrolled in their collaborative UNCOVER study or “The RECOVER Sub-Study, Which Leverages Quantitative and Credible Research Tools from Verily

BioCardia®, Inc. [Nasdaq: BCDA], today announced that it has entered into an agreement with a leading Japanese biotechnology company related to BioCardia Helix catheter biotherapeutic delivery product candidates.

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Johns Hopkins University School of Medicine is starting an investigator-initiated trial of non-invasive vagus nerve stimulation (nVNS) using the Company’s proprietary gammaCore device to treat symptomatic exacerbation of nausea in patients with gastroparesis and related disorders (NCT04857281).

Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments for non-alcoholic steatohepatitis (NASH), today announced the appointment of Yuan Xu, Ph.D., to its board of directors as an independent director.